CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ZGOO Holdings Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ZGOO Holdings Co Ltd
4F, 321-1, Ttukseom-ro, Seongdong-gu
Phone: +82 215771338p:+82 215771338 SEOUL, 04779  South Korea Ticker: 221800221800
Business Summary
ZGOO Holdings Co Ltd, formerly U2Bio Co Ltd, is a Korea-based holding company engaged in providing in vitro diagnostic (IVD) testing services. The Company operates through three businesses. The IVD testing service business mainly includes general diagnostic testing services and molecular diagnostic testing services. The general diagnostic testing services provide diagnostic information and reagents for immunoserology, hematology, urinalysis, microbiology, and pathology through the testing of proteins, carbohydrates, metabolites, and cells. The molecular diagnostic testing services provide molecular tests, COVID-19 tests, non-medical health screenings, IVD medical devices, diagnostic kits, and testing reagents. The medical information technology (IT) solution business provides systems and other related information technology services to support and manage administrative and medical activities within hospitals. The new business supplies clinical trial services and healthcare solutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
8071 Medical laboratories
2835 In vitro and in vivo diagnostic substances
7373 Computer integrated systems design
6719 Offices of holding companies, not elsewhere classified
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jin TaeKim 61
Assistant Managing Director Ji WonKim 54 1/1/2024 1/1/2024
Assistant Managing Director Hyeok SeongJin 53 1/1/2024 1/1/2024
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 102 (As of 9/30/2025)
Outstanding Shares: 16,232,474 (As of 4/27/2026)
Shareholders: 7,101
Stock Exchange: KDQ
Fax Number: +82 29410482


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026